322 related articles for article (PubMed ID: 11045309)
1. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
3. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
[TBL] [Abstract][Full Text] [Related]
5. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
Kingwatanakul P; Warady BA
Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
8. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus CAPD-related infections are associated with nasal carriage.
Lye WC; Leong SO; van der Straaten J; Lee EJ
Adv Perit Dial; 1994; 10():163-5. PubMed ID: 7999818
[TBL] [Abstract][Full Text] [Related]
10. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
12. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
Al-Hwiesh AK; Abdul Rahman IS
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
14. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
Ritzau J; Hoffman RM; Tzamaloukas AH
Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F
N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
17. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS).
Oh J; von Baum H; Klaus G; Schaefer F
Adv Perit Dial; 2000; 16():324-7. PubMed ID: 11045321
[TBL] [Abstract][Full Text] [Related]
18. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
19. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
Cavdar C; Atay T; Zeybel M; Celik A; Ozder A; Yildiz S; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():67-70. PubMed ID: 15384798
[TBL] [Abstract][Full Text] [Related]
20. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
